Related Experiment Video
Updated: Sep 23, 2025

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes
Published on: April 13, 2018
Regulation of protein complex partners as a compensatory mechanism in aneuploid tumors
Gökçe Senger1, Stefano Santaguida1,2, Martin H Schaefer1
1Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
Abstract:
Aneuploidy, a state of chromosome imbalance, is a hallmark of human tumors, but its role in cancer still remains to be fully elucidated. To understand the consequences of whole-chromosome-level aneuploidies on the proteome, we integrated aneuploidy, transcriptomic, and proteomic data from hundreds of The Cancer Genome Atlas/Clinical Proteomic Tumor Analysis Consortium tumor samples. We found a surprisingly large number of expression changes happened on other, non-aneuploid chromosomes. Moreover, we identified an association between those changes and co-complex members of proteins from aneuploid chromosomes. This co-abundance association is tightly regulated for aggregation-prone aneuploid proteins and those involved in a smaller number of complexes. On the other hand, we observed that complexes of the cellular core machinery are under functional selection to maintain their stoichiometric balance in aneuploid tumors. Ultimately, we provide evidence that those compensatory and functional maintenance mechanisms are established through post-translational control, and that the degree of success of a tumor to deal with aneuploidy-induced stoichiometric imbalance impacts the activation of cellular protein degradation programs and patient survival.
Insights
Aneuploidy, or chromosome imbalance, impacts tumor proteomes by altering protein expression. Tumors develop compensatory mechanisms to manage this imbalance, influencing patient survival.
Area of Science:
- Cancer Biology
- Genomics
- Proteomics
Background:
- Aneuploidy, a deviation from the normal chromosome number, is common in human cancers.
- The precise role of aneuploidy in cancer progression and its impact on the proteome are not fully understood.
Purpose of the Study:
- To investigate the proteomic consequences of whole-chromosome aneuploidies in human tumors.
- To identify regulatory mechanisms tumors employ to cope with aneuploidy-induced stoichiometric imbalances.
Main Methods:
- Integration of multi-omics data, including aneuploidy status, transcriptomics, and proteomics.
- Analysis of hundreds of The Cancer Genome Atlas/Clinical Proteomic Tumor Analysis Consortium tumor samples.
- Examination of protein co-abundance and complex stoichiometry in aneuploid tumors.
Main Results:
- Aneuploidy leads to widespread expression changes, not only on aneuploid chromosomes but also on non-aneuploid ones.
- Proteins from aneuploid chromosomes show co-abundance with their complex members, with tighter regulation for aggregation-prone proteins.
- Cellular machinery complexes exhibit functional selection to maintain stoichiometric balance despite aneuploidy.
Conclusions:
- Tumors utilize post-translational modifications to establish compensatory and functional maintenance mechanisms against aneuploidy.
- The effectiveness of these mechanisms in managing stoichiometric imbalance correlates with protein degradation pathways and patient survival.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Anaphase Promoting Complex
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Positive Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

